Revascularisation of Left Main Stem Disease: a Prospective Analysis of Modern Practice and Outcomes in a Non-surgical Centre

Overview

Journal Open Heart

Publisher BMJ Publishing Group

Specialty Cardiology & Vascular Diseases

Date 2018 Jul 19

PMID 30018777

Citations 1

Authors

J J Coughlan

Nial Blake

Napohn Chongprasertpon

Munir Ibrahim

Samer Arnous

Thomas John Kiernan

Affiliations

Soon will be listed here.

Abstract

Purpose: In this study, we sought to prospectively analyse the management and long term outcomes associated with revascularisation of left main stem disease via percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in our centre.

Methods: This prospective study enrolled all patients with unprotected left main stem disease undergoing revascularisation from January 2013 to June 2014. Baseline characteristics, hospital presentation and hospital stay length were collected. Patients were followed up at 1, 2 and 3 years. Primary outcomes of Major Adverse Cardiovascular and Cerebrovascular Events (MACCE) were defined as death, Q wave myocardial infarction, stroke, repeat revascularisation and readmission within 30 days.

Results: 56 patients with significant left main stem coronary artery disease were identified from the clinical registry. 27 patients underwent PCI (median age 67.7) and 29 CABG (median age 68.6). PCI patients had a higher surgical risk as measured by mean euroSCORE (4.95±5.8 vs 3.11±3.85). At 3 years, total MACCE occurred in 29.6% of the PCI cohort and 27.5% of the CABG cohort. Death occurred in three patients in the PCI group within the first 6 months. Death occurred in one patient in the CABG group over 2 years postprocedure. Two patients in the CABG cohort presented with Transient Ischemic Attacks (TIAs) at 2-year follow-up. At 3 years, revascularisation occurred in three patients in the PCI cohort. There were no revascularisation events in the CABG cohort.

Conclusions: PCI with modern drug eluting stents is a reasonable treatment option for unprotected left main stem disease in a non surgical centre.

Citing Articles

Safety and efficacy of percutaneous coronary intervention versus coronary artery bypass graft in patients with STEMI and unprotected left main stem disease: A systematic review & meta-analysis.

Almas T, Afzal A, Fatima H, Yaqoob S, Jarullah F, Abbasi Z Int J Cardiol Heart Vasc. 2022; 40:101041.

PMID: 35655530 PMC: 9152298. DOI: 10.1016/j.ijcha.2022.101041.

References

Wood F, Saylors E, Schneider J, Jobe R, Mann 3rd J . Unprotected left main disease managed with drug-eluting stents: long-term outcome of 100 patients with increased surgical risk. Catheter Cardiovasc Interv. 2008; 71(4):533-8. DOI: 10.1002/ccd.21447. View

Haan C, OBrien S, Edwards F, Peterson E, Ferguson T . Trends in emergency coronary artery bypass grafting after percutaneous coronary intervention, 1994-2003. Ann Thorac Surg. 2006; 81(5):1658-65. DOI: 10.1016/j.athoracsur.2005.09.079. View

Stone G, Sabik J, Serruys P, Simonton C, Genereux P, Puskas J . Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease. N Engl J Med. 2016; 375(23):2223-2235. DOI: 10.1056/NEJMoa1610227. View

Makikallio T, Holm N, Lindsay M, Spence M, Erglis A, Menown I . Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. Lancet. 2016; 388(10061):2743-2752. DOI: 10.1016/S0140-6736(16)32052-9. View

Gaziano T, Bitton A, Anand S, Abrahams-Gessel S, Murphy A . Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol. 2010; 35(2):72-115. PMC: 2864143. DOI: 10.1016/j.cpcardiol.2009.10.002. View

Giannoglou G, Antoniadis A, Chatzizisis Y, Damvopoulou E, Parcharidis G, Louridas G . Prevalence of narrowing >or=50% of the left main coronary artery among 17,300 patients having coronary angiography. Am J Cardiol. 2006; 98(9):1202-5. DOI: 10.1016/j.amjcard.2006.05.052. View

Deb S, Wijeysundera H, Ko D, Tsubota H, Hill S, Fremes S . Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review. JAMA. 2013; 310(19):2086-95. DOI: 10.1001/jama.2013.281718. View

Mehilli J, Kastrati A, Byrne R, Bruskina O, Iijima R, Schulz S . Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol. 2009; 53(19):1760-8. DOI: 10.1016/j.jacc.2009.01.035. View

Kolh P, Windecker S . ESC/EACTS myocardial revascularization guidelines 2014. Eur Heart J. 2014; 35(46):3235-6. DOI: 10.1093/eurheartj/ehu422. View

10.

Sa M, Soares A, Lustosa P, Martins W, Browne F, Ferraz P . Meta-analysis of 5,674 patients treated with percutaneous coronary intervention and drug-eluting stents or coronary artery bypass graft surgery for unprotected left main coronary artery stenosis. Eur J Cardiothorac Surg. 2012; 43(1):73-80. DOI: 10.1093/ejcts/ezs204. View

11.

KALBFLEISCH H, Hort W . Quantitative study on the size of coronary artery supplying areas postmortem. Am Heart J. 1977; 94(2):183-8. DOI: 10.1016/s0002-8703(77)80278-0. View

12.

Head S, Farooq V, Serruys P, Kappetein A . The SYNTAX score and its clinical implications. Heart. 2013; 100(2):169-77. DOI: 10.1136/heartjnl-2012-302482. View

13.

Sa M, Soares A, Miranda R, Araujo M, Menezes A, Silva F . CABG Surgery Remains the best Option for Patients with Left Main Coronary Disease in Comparison with PCI-DES: Meta-Analysis of Randomized Controlled Trials. Braz J Cardiovasc Surg. 2017; 32(5):408-416. PMC: 5701106. DOI: 10.21470/1678-9741-2017-0081. View

14.

Vignali L, Talanas G, Menozzi A, Cattabiani M, Solinas E, Aurier E . Long-term mortality in patients unsuitable for surgical revascularization undergoing elective left main coronary artery angioplasty. Minerva Cardioangiol. 2008; 56(1):1-11. View

15.

Patel N, De Maria G, Kassimis G, Rahimi K, Bennett D, Ludman P . Outcomes after emergency percutaneous coronary intervention in patients with unprotected left main stem occlusion: the BCIS national audit of percutaneous coronary intervention 6-year experience. JACC Cardiovasc Interv. 2014; 7(9):969-80. DOI: 10.1016/j.jcin.2014.04.011. View

16.

Mathers C, Loncar D . Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006; 3(11):e442. PMC: 1664601. DOI: 10.1371/journal.pmed.0030442. View

17.

Cohen M, Gorlin R . Main left coronary artery disease. Clinical experience from 1964-1974. Circulation. 1975; 52(2):275-85. DOI: 10.1161/01.cir.52.2.275. View

18.

Hillis L, Smith P, Anderson J, Bittl J, Bridges C, Byrne J . 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for.... J Am Coll Cardiol. 2011; 58(24):e123-210. DOI: 10.1016/j.jacc.2011.08.009. View

19.

Taylor H, Deumite N, Chaitman B, Davis K, Killip T, Rogers W . Asymptomatic left main coronary artery disease in the Coronary Artery Surgery Study (CASS) registry. Circulation. 1989; 79(6):1171-9. DOI: 10.1161/01.cir.79.6.1171. View

20.

Sa M, Ferraz P, Escobar R, Nunes E, Soares A, Sa F . Five-year outcomes following PCI with DES versus CABG for unprotected LM coronary lesions: meta-analysis and meta-regression of 2914 patients. Rev Bras Cir Cardiovasc. 2013; 28(1):83-92. DOI: 10.5935/1678-9741.20130013. View